{"id":"https://openalex.org/W4362416640","doi":"https://doi.org/10.1158/1078-0432.22481009","title":"Supplementary Data from Phase I/Ib Clinical Trial of Sabatolimab, an Anti\u2013TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti\u2013PD-1 Antibody, in Advanced Solid Tumors","display_name":"Supplementary Data from Phase I/Ib Clinical Trial of Sabatolimab, an Anti\u2013TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti\u2013PD-1 Antibody, in Advanced Solid Tumors","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362416640","doi":"https://doi.org/10.1158/1078-0432.22481009"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22481009","doi":"https://doi.org/10.1158/1078-0432.22481009","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481009","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22481009","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003897511","display_name":"Giuseppe Curigliano","orcid":"https://orcid.org/0000-0003-1781-2518","observed_orcids":["https://orcid.org/0000-0003-1781-2518"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giuseppe Curigliano","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1781-2518","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025935523","display_name":"Hans A. J. Gelderblom","orcid":"https://orcid.org/0000-0001-9270-8636","observed_orcids":["https://orcid.org/0000-0001-9270-8636"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans Gelderblom","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9270-8636","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020235177","display_name":"Nicolas Mach","orcid":"https://orcid.org/0000-0001-8944-1088","observed_orcids":["https://orcid.org/0000-0001-8944-1088"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicolas Mach","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8944-1088","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001115937","display_name":"Toshihiko Doi","orcid":"https://orcid.org/0000-0003-2042-6829","observed_orcids":["https://orcid.org/0000-0003-2042-6829"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshihiko Doi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2042-6829","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089860988","display_name":"David Wai-Meng Tai","orcid":"https://orcid.org/0000-0002-2612-0065","observed_orcids":["https://orcid.org/0000-0002-2612-0065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Tai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059543131","display_name":"Patrick M. Forde","orcid":"https://orcid.org/0000-0001-6925-6344","observed_orcids":["https://orcid.org/0000-0001-6925-6344"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick M. Forde","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057503413","display_name":"John Sarantopoulos","orcid":"https://orcid.org/0009-0002-4395-136X","observed_orcids":["https://orcid.org/0009-0002-4395-136X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Sarantopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041145711","display_name":"Philippe Lucien Bedard","orcid":"https://orcid.org/0000-0002-6771-2999","observed_orcids":["https://orcid.org/0000-0002-6771-2999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe L. Bedard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6771-2999","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036446086","display_name":"Chia\u2010Chi Lin","orcid":"https://orcid.org/0000-0002-2573-5789","observed_orcids":["https://orcid.org/0000-0002-2573-5789"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chia-Chi Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2573-5789","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084967339","display_name":"Frank Stephen Hodi","orcid":"https://orcid.org/0000-0001-6825-091X","observed_orcids":["https://orcid.org/0000-0001-6825-091X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Stephen Hodi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033241663","display_name":"Sofie Wilgenhof","orcid":"https://orcid.org/0000-0002-3309-4555","observed_orcids":["https://orcid.org/0000-0002-3309-4555"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sofie Wilgenhof","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100766578","display_name":"Armando Santoro","orcid":"https://orcid.org/0000-0003-1709-9492","observed_orcids":["https://orcid.org/0000-0003-1709-9492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Armando Santoro","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1709-9492","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082387745","display_name":"Catherine A. Sabatos-Peyton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine A. Sabatos-Peyton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028511731","display_name":"Tyler A. Longmire","orcid":"https://orcid.org/0000-0002-1621-1895","observed_orcids":["https://orcid.org/0000-0002-1621-1895"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tyler A. Longmire","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033767394","display_name":"Alexandros Xyrafas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandros Xyrafas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100563167","display_name":"Haiying Sun","orcid":"https://orcid.org/0000-0002-3280-8800","observed_orcids":["https://orcid.org/0000-0002-3280-8800"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haiying Sun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029244372","display_name":"Sabine Gutzwiller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabine Gutzwiller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110243","display_name":"Luigi Manenti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luigi Manenti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005436649","display_name":"Aung Naing","orcid":"https://orcid.org/0000-0002-4803-8513","observed_orcids":["https://orcid.org/0000-0002-4803-8513"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aung Naing","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4803-8513","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tim-3","display_name":"TIM-3","score":0.9200000166893005},{"id":"https://openalex.org/keywords/anti-tim-3-antibody","display_name":"anti-TIM-3 antibody","score":0.8100000023841858},{"id":"https://openalex.org/keywords/spartalizumab","display_name":"spartalizumab","score":0.9089999794960022},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.7689999938011169},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.8870000243186951},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9319999814033508}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6543444395065308},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.49592384696006775},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44350650906562805},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37714093923568726},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3398118019104004},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3385777473449707},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3052123785018921},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.25216060876846313},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22481009","doi":"https://doi.org/10.1158/1078-0432.22481009","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481009","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22481009","doi":"https://doi.org/10.1158/1078-0432.22481009","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22481009","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W15021325","https://openalex.org/W2108895381","https://openalex.org/W2028771196","https://openalex.org/W2040267802","https://openalex.org/W2493094138","https://openalex.org/W3011298586","https://openalex.org/W2074504229","https://openalex.org/W1979187662","https://openalex.org/W4313377073","https://openalex.org/W1966441254"],"abstract_inverted_index":{"Supplementary":[0],"Materials":[1]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}